PI-88: PGL will begin in July a U.S. Phase I trial of PI-88 in combination with Taxotere docetaxel from Aventis S.A. (AVE, Strasbourg, France). The trial will e

Progen Industries Ltd. (ASX:PGL; PGLAF), Brisbane, Australia

Read the full 85 word article

How to gain access

Continue reading with a
two-week free trial.